Literature DB >> 19442186

Purinergic receptors and pain.

Geoffrey Burnstock1.   

Abstract

There is a brief summary of the early background literature about purinergic signalling and its involvement in pain, of ATP storage, release and ectoenzymatic breakdown and of the current classification of receptor subtypes for purines and pyrimidines. The review then focuses on purinergic mechanosensory transduction involved in visceral, cutaneous and musculoskeletal nociception and on the roles played by P2X-(3), P2Y(2/3), P2X(4), P2X(7) and P2Y(12) receptors in neuropathic and inflammatory pain. Current developments of compounds for the therapeutic treatment of both visceral and neuropathic pain are discussed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19442186     DOI: 10.2174/138161209788186335

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  62 in total

1.  Contributions of purinergic P2X3 receptors within the midbrain periaqueductal gray to diabetes-induced neuropathic pain.

Authors:  Jianfei Guo; Xudong Fu; Xia Cui; Minhua Fan
Journal:  J Physiol Sci       Date:  2014-11-01       Impact factor: 2.781

2.  Identification of P2X₃ and P2X₇ purinergic receptors activated by ATP in rat lacrimal gland.

Authors:  Robin R Hodges; Joanna Vrouvlianis; Rachel Scott; Darlene A Dartt
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-05-17       Impact factor: 4.799

3.  Expression of P2X5 receptors in the rat, cat, mouse and guinea pig dorsal root ganglion.

Authors:  Jun-Wei Zeng; Sai-Yu Cheng; Xiao-Hong Liu; Yan-Dong Zhao; Zhi Xiao; Geoffrey Burnstock; Huai-Zhen Ruan
Journal:  Histochem Cell Biol       Date:  2012-11-18       Impact factor: 4.304

4.  The role of P2X7 purinergic receptors in inflammatory and nociceptive changes accompanying cyclophosphamide-induced haemorrhagic cystitis in mice.

Authors:  J P Martins; R B M Silva; R Coutinho-Silva; C M Takiya; A M O Battastini; F B Morrone; M M Campos
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

Review 5.  Meeting acute migraine treatment needs through novel treatment formulations.

Authors:  Stephen D Silberstein
Journal:  Neurotherapeutics       Date:  2010-04       Impact factor: 7.620

6.  Nanoparticle-encapsulated emodin decreases diabetic neuropathic pain probably via a mechanism involving P2X3 receptor in the dorsal root ganglia.

Authors:  Lin Li; Xuan Sheng; Shanhong Zhao; Lifang Zou; Xinyao Han; Yingxin Gong; Huilong Yuan; Liran Shi; Lili Guo; Tianyu Jia; Shuangmei Liu; Bing Wu; Zhihua Yi; Hui Liu; Yun Gao; Guilin Li; Guodong Li; Chunping Zhang; Hong Xu; Shangdong Liang
Journal:  Purinergic Signal       Date:  2017-08-24       Impact factor: 3.765

7.  CD73 Controls Extracellular Adenosine Generation in the Trigeminal Nociceptive Nerves.

Authors:  X Liu; L Ma; S Zhang; Y Ren; R T Dirksen
Journal:  J Dent Res       Date:  2017-02-16       Impact factor: 6.116

8.  lncRNA NONRATT021972 siRNA Decreases Diabetic Neuropathic Pain Mediated by the P2X3 Receptor in Dorsal Root Ganglia.

Authors:  Haiying Peng; Lifang Zou; Jinyan Xie; Hong Wu; Bing Wu; Gaochun Zhu; Qiulan Lv; Xi Zhang; Shuangmei Liu; Guilin Li; Hong Xu; Yun Gao; Changshui Xu; Chunping Zhang; Shouyu Wang; Yun Xue; Shangdong Liang
Journal:  Mol Neurobiol       Date:  2016-01-07       Impact factor: 5.590

9.  Morphine enhances IL-1β release through toll-like receptor 4-mediated endocytic pathway in microglia.

Authors:  Yongxin Liang; Haichen Chu; Yanan Jiang; Li Yuan
Journal:  Purinergic Signal       Date:  2016-08-09       Impact factor: 3.765

10.  The postsynaptic function of type II cochlear afferents.

Authors:  Catherine Weisz; Elisabeth Glowatzki; Paul Fuchs
Journal:  Nature       Date:  2009-10-22       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.